OvaScience
- Pharmaceutical Preparations
- Brisbane, California
Compensation history
Top executives at OvaScience received an average of $2M per person in annual compensation from 2011 to 2023.
Average pay of disclosed executives at OvaScience
By year
Executives
We found 22 executives who work or worked at OvaScience.
Stephen Brady
OvaScience
Chief Executive Officer
Samuel Whiting
OvaScience
Chief Medical Officer
Nicholas Maestas
OvaScience
VP, Strategy and Finance
Thomas Dubensky
OvaScience
President
Julia Owens
OvaScience
Chief Executive Officer
Louis Arcudi
OvaScience
Chief Executive Officer
Ryan Zeidan
OvaScience
Chief Development Officer
Pharis Mohideen
OvaScience
Chief Medical Officer
News
OvaScience CEO Stephen Brady's 2023 pay jumps 363% to $7M
April 23, 2024
OvaScience CEO Stephen Brady's 2022 pay jumps 112% to $1.5M
May 1, 2023
OvaScience CEO Louis Arcudi's 2021 pay jumps 67% to $1.6M
May 2, 2022
OvaScience CEO Julia Owens' 2019 pay slips 2% to $2.4M
April 24, 2020
OvaScience CEO Julia Owens' 2018 pay jumps 307% to $2.4M
April 29, 2019
About OvaScience
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address2000 Sierra Point Parkway, Suite 400, Brisbane, California 94005
- Phone415-798-8589
- Fiscal year endDecember 31
- Former names
- Millendo Therapeutics, Inc.Until June 30, 2021
- OvaScience, Inc.Until December 5, 2018
Source: SEC filings on April 23, 2024, May 1, 2023, May 2, 2022, April 24, 2020, April 29, 2019, April 26, 2017, April 18, 2016, April 30, 2014, and April 26, 2013.